Autism research / A mission with a measured path
SeaKing Solace is developing precision motion technology with the potential to improve quality of life for autistic people and their families. Our research and engineering program brings controlled movement, physiological measurement, and software together to inform future autism intervention.
The intended platform would allow defined motion and physiological responses to be studied together, with the long-term goal of informing meaningful therapeutic approaches.
Development should be guided by the needs and priorities of autistic people, alongside families, clinicians, and researchers. Comfort, tolerability, participation, and everyday quality of life are areas to consider when designing meaningful future evaluations.
The scientific rationale
The vestibular system senses movement and orientation. Its connections with sensory processing and autonomic physiology give the program a defined scientific starting point.
Vestibular signals are integrated with vision, body position, and other sensory information. Published research also examines connections between vestibular input and cardiovascular and autonomic responses. SeaKing Solace brings these fields together to guide what the program measures.
Explore the vestibular and autonomic evidence →Studies of motion-rich activities, including therapeutic horseback riding, provide relevant human evidence. Those activities combine movement with other experiences, and their findings belong to the people and protocols studied. Our review examines what can inform a future controlled-motion platform and where direct measurement is still needed.
Read the autism-specific evidence discussion →The proposed Phase 1 SAIL study characterizes natural vessel motion and synchronized physiological responses in healthy adults. The immediate purpose is to inform the product's software, sensing, and engineering.
The vessel, the seat, and the participant can move differently. Measuring the motion actually received helps define the inputs a future simulator would need to deliver and monitor.
Synchronizing motion and physiological measurements allows the research team to examine response patterns, their consistency, and alternative explanations. Those findings inform calibration, sensor requirements, and control software.
Beginning with characterization in healthy adults addresses the measurement and engineering questions that come before an autism-specific clinical evaluation. The autism mission guides the destination; this first stage supplies information needed to design the technology and its later studies.
The long-term ambition is a useful, accessible therapeutic technology. Reaching that destination requires engineering work and direct clinical evaluation with the people it is intended to serve.
Translate supported measurements into a prototype, then evaluate technical performance, tolerability, and candidate protocols.
Future autism-specific studies would evaluate safety and meaningful outcomes through their own protocols, participant protections, and applicable approvals.
Evidence would guide the intended use, suitable populations, clinical requirements, and practical route toward access.
Questions about the program
SeaKing Solace is developing a future therapeutic platform. Concepts and engineering design exist; the platform is not currently offered as an established autism treatment. Its therapeutic safety and effectiveness have not been established. Phase 1 is in planning and has not begun.
Read the current clinical and development statusSeaKing Solace is in research and engineering development. The proposed Phase 1 SAIL study is in planning and involves healthy adults. Autism-specific clinical studies are a later development step, informed by the measurements, engineering, and evidence built along the way.
See the five intended development stagesSeaKing Solace is pursuing a research and engineering pathway for precision motion technology. Its scientific rationale draws on published vestibular, autonomic, and human intervention literature. Later autism-specific evaluation would need to establish whether a defined use is safe and provides meaningful benefit. The white papers explain the rationale and the questions that remain.
Explore the evidence and development questionsAutistic people, families, clinicians, and researchers can explore the scientific reviews, follow program updates, and ask questions about the development pathway. Scientists and clinicians interested in measurement, study design, or future clinical research can explore scientific collaboration.
Explore scientific collaborationOutside research use, the plan is to invite families of children with special needs aboard for cruising experiences and opportunities to connect. This community vision creates space for shared adventures and stronger relationships among families who too often feel unseen.
Explore the family and community visionAdditional pathways
Broader potential comes from the platform's intended ability to characterize and deliver motion—not from assuming that a response in one population transfers to another.
Future studies could investigate relevance to defined autonomic conditions, including POTS, where a specific scientific rationale supports evaluation. Safety, response patterns, and benefit would need to be studied directly.
Potential development could examine applications where vestibular, sensorimotor, and autonomic interactions are relevant to a defined rehabilitation question. No rehabilitation indication is established for this platform.
Build what comes next
Explore philanthropy, investment, and sponsorship to find the funding path that fits you.
